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Eye Complications of Acquired Immune Deficiency Syndrome (AIDS) 
Part 1. Ocular surface and anterior segment manifestations 
Wani MGa, Eye Department, Mutare Provincial Hospital, P O Box 2481, Mutare, Zimbabwe 
Introduction 
Acquired Immune Deficiency Syndrome (AIDS) is the leading cause of sickness and death among young adults in 
developing countries. The introduction of highly active anti-retroretroviral therapy (HAART) has changed the epidemiology 
of AIDS from being a universally fatal illness to a chronic debilitating infection attended by multi-organ complications. 
Improved survival as a result of HAART has lead to increase in systemic and ocular complications as well as the appearance 
of syndromes related to immune reconstitution. HIV associated eye disease now occurs in 50-90% of patients at one point 
in the course of their illness1. Loss of sight is a feared complication because of its impact on the management of the 
systemic disease and the additional distress experienced by the patient who now has to rely on others for assistance with 
activities of daily living.  This paper reviews anterior segment and external ocular disorders associated with AIDS in an 
effort to improve understanding of this disorder and facilitate early detection, referral and care of those presenting to any 
level of the health delivery system in South Sudan.  
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Southern Sudan is a country that has endured two 
decades of conflict during which infrastructure was 
destroyed and the population displaced to internally 
displaced camps and neighbouring countries. 
Although no population studies have been 
conducted to determine the prevalence of HIV in 
South Sudan, hospital based surveys suggest that 
prevalence may be low compared to that of countries 
in the region. This is likely to change and prevalence 
could increase rapidly due to increased movement 
within and between South Sudan and its neighbours. 
The prevalence of eye complications of HIV is 
likewise expected to increase, as patients survive 
longer due to availability of more effective anti-
retroviral therapy and improved treatment for and 
prophylaxis against opportunistic infections. Eye 
complications of HIV can involve any ocular tissue 
and may indicate worsening of the underlying 
immune disorder. In some cases an eye lesion is the 
first sign of disease in a previously healthy patient. 
Diagnosis and treatment of anterior segment 
disorders and adnexial disease is an important 
component of comprehensive eye care strategy for 
HIV patients and must be undertaken aggressively in 
order to prevent disfigurement, preserve dignity and 
improve quality of life. 
 
 Table 1 describes the main eye complications of 
HIV and their relationship to CD4 count. This 
article focuses on those complications occurring on 
the anterior segment and adnexia that are easily 
recognised by inspection. Posterior segment and 
neuro-ophthalmological complications are difficult 
to diagnose at primary care level. Their diagnosis 
requires specialist knowledge and use of 
sophisticated equipment. A high index of suspicion 
should be maintained and prompt referral to an 
ophthalmologist made for any HIV patient who 
presents with cranial nerve palsies or complains of 
visual loss in a normally appearing eye.  Detailed 
discussion of these complications will be the subject 
of a separate article.  
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Opportunistic Infections of Ocular Adnexia 
Herpes Zoster Ophthalmicus (HZO) 
Herpes Zoster is caused by varicella zoster virus, 
which is a member of the herpes virus group. 
Primary infection occurs in early childhood when it 
presents as chicken pox, a self-limiting generalised 
exanthema that rarely involves the eye and heals 
without sequela. Following primary infection the 
virus migrates to the trigeminal ganglion where it 
remains quiescent for many years.  If cell mediated 
immunity is reduced for any reason including 
infection with Human Immunodeficiency Virus 
(HIV), cancer or immunosuppressive therapy, the 
virus becomes activated and travels down the 
branches of the trigeminal nerve causing a typical 
vesicular rash (figure 1). The ophthalmic division of 
the trigeminal nerve is involved more frequently than 
other branches, hence the name Herpes Zoster 
Ophthalmicus (HZO). It occurs early in the course 
of HIV infection when the CD4 count is more than 
200 cells/µl. It is therefore not considered an AIDS 
defining illness although its occurrence in a young 
person should raise the possibility of immune 
suppression. HZO occurs more commonly in Africa 
than Europe and the United States2 where 
Cytomegalovirus infection is more common. Other 
complications of HZO include inflammation and 
loss of sensation of the cornea (Neurotrophic keratitis), 
inflammation of the sclera, iris and retina (sleritis, iritis 
and retinitis). Herpetic neuralgia (PHN) refers to 
debilitating pain and itching in the involved branch 
of the nerve persisting many months after healing of 
the acute lesion.  It is due to irritation of nerve 
endings by the resulting scar tissue. Presence of a 
blister on the tip of the nose predicts eye 
involvement and should prompt early treatment with 
systemic steroids, in order to lessen severity of eye 
disease.   
 
 
Figure 1. Herpes Zoster Ophthalmicus 
 
Diagnosis of HZO can usually be made clinically 
without the need for laboratory work up. Treatment 
should begin with intravenous Acyclovir 10mg/kg 
for 5 days followed by oral Acyclovir 800mg five 
times daily for 9 days. This limits the duration of 
skin rash and reduces the prevalence of 
inflammatory eye complications. Patients who 
develop iridocyclitis and/or stromal keratitis may be 
treated with topical steroids. Options for treatment 
of PHN if it develops include:  
• Topical lidocaine cream plus tricyclic 
antidepressants; 
• Amitriptyline 50 mg nocte or  
• Carbamazepine 200 mg every night.  
Systemic steroids and antivirals may prevent loss of 
sight from uveitis and keratitis. 
Molluscum Contagiosium 
This is an infection caused by the poxvirus and is 
acquired sexually or through direct contact. It 
presents as small painless elevated round pearly 
white nodules about 2-4 mm in size around the eyes. 
Central umbilication is pathognomonic and 
differentiates it from other nodules of similar 
appearance3. Inflammation of the conjunctiva and 
cornea may occur as a complication. Disseminated 
lesions may occur in severe immune-suppression. 
Single or isolated lesions can be treated by curettage, 
excision or cryotherapy. Disseminated lesions can be 
treated by oral acyclovir. Reconstitution of immune 
function with HAART can result in resolution of 
molluscum contagiosium lesions without concurrent 
use of specific therapy.  
Ocular Adnexal Tumours 
Kaposi Sarcoma 
Kaposi Sarcoma is a malignant vascular tumour 
caused by Human Herpes Virus 8 (HHV-8)4 that 
was originally reported in elderly males of 
Mediterranean origin and Jewish ancestry. It affects 
skin, mucus membrane, internal organs and lymph 
nodes. Ocular Kaposi Sarcoma (figure 2) presents on 
the lid or conjunctiva as a painless diffuse violet 
nodule.  Prior to the advent of the AIDS epidemic, 
ocular Kaposi Sarcoma was a rare entity reported in 
less than 30 cases worldwide. It is now one of the 
commonest malignant tumours in AIDS patients and 
not uncommonly the first manifestation of infection 
with the HIV virus. 
 
 
Figure 2. Kaposi Sarcoma of the lid presenting as a purple nodule 
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The main postulated mode of transmission is sexual5 
although vertical transmission from mother to child 
is thought to be common in sub-Saharan Africa6,7 
where the disease is endemic.  Multiple factors may 
interact with HIV to cause Kaposi Sarcoma. This 
includes deregulated expression of oncogenes, 
decreased immune surveillance and release of 
Cytokines and Growth factors by the action of HIV 
upon infected cells. Although science is still far from 
understanding the mechanism by which HHV-8 
causes oncogensis, some viral oncogenes believed to 
contribute to neoplasia have been isolated.  Latency 
Associated Nuclear Antigen (LANA) encoded by 
HHV-8 genome is a protein consistently shown to 
be expressed in HHV infected cells. LANA interacts 
with tumour suppressor genes in a manner that 
promotes oncogensis. Treatment may include 
surgical resection. Regression may be achieved with 
radiotherapy or chemotherapy with Bleomycin  
Squamous cell carcinoma of the conjunctiva 
(SCC) 
SCC is the most common malignancy of the 
conjunctiva. The incidence of the indolent form of 
this disease has been shown to decline as one travels 
away from the equator. Thus in Uganda, an 
incidence of 1.2/100,000 persons/year has been 
reported compared to 0.02/100,000 persons/year in 
the UK which is further north of the equator8. The 
most common presentation is that of a friable white 
or pigmented nodule at the junction of the sclera 
with cornea (figure 3).  This form of the tumour 
presents mainly in elderly African males who spend 
many hours in the sun working on farms or other 
occupations. Fair skin pigmentation, UV radiation 
and atopic eczema are the main risk factors for this 
form of SCC.  It rarely invades the eyeball or 
adjacent structures and death is uncommon. Margin 
free surgery followed by cryotherapy or radiation has 
100% cure rate. Recurrent lesions are treated with 
topical Mitomycin C, 5FU or interferon Alpha9  
 
Figure 3. Squamous cell carcinoma of the conjunctiva presenting as a white 
mass with rough friable surface 
 
An aggressive form of SCC has recently been 
described in young adults less than 50 years of age in 
whom the disease progresses relentlessly, invading 
the eyeball, orbit and adjacent adnexial tissue10 and 
metastasising to regional lymph nodes11. Studies in 
Rwanda, Malawi and Uganda12 have found high 
association of HIV with this form of SCC. In 
Zimbabwe, a nine-fold increase in cases from six 
cases/million to 35 cases/million in less than 5 years 
has been recorded since the onset of the HIV 
epidemic13. High titres of Human Papilloma Virus 
(HPV) type 16, 18 have been found in association 
with this tumour, raising the possibility that it may be 
caused by an infectious agent. It is not known 
precisely how HIV interacts with HPV and other 
oncogenic viruses to cause the aggressive form of 
this disease.  
 
Theories abound that HIV directly induces 
neoplastic change in tissue by secreting viral 
oncogenes that inactivates tumour suppressor gene 
products secreted by host tissues, thereby promoting 
oncogensis. Integration of viral genome into host 
tissue is also postulated to lead to neoplastic 
transformation.  
 
HIV induced immune suppression may reduce 
immune surveillance thereby priming the tissue for 
malignant transformation as has been the case in 
liver transplant patients who receive Azothriopine 
therapy14. HPV is known to increase the activity of 
Transforming growth factor Beta (TGFβ) which promotes 
differentiation and neoplastic transformation of cells. 
Pan activation of humeral immune system and 
increase in Cytokine release leads to a chronic 
inflammatory state that facilitates malignant 
transformation15. 
 
If the tumour is diagnosed early before it infiltrates 
the eyeball or conjunctiva of the lid, wide excision 
has 100% cure rate. A tumour that is fixed to the 
eyeball should be treated by enucleation of the eye to 
prevent lid invasion and subsequent systemic spread 
through vascular and lymphatic route. In Sakubva 
Eye Unit, Mutare, SCC is the commonest cause of 
enucleation of the eye in adults and a frequent cause 
of death from eye related disease among HIV 
patients. Early diagnoses followed by wide excision 
or enucleation can relieve pain and improve the 
quality of life of affected patients  
 
Other conditions associated with HIV  
Anterior Uveitis 
Inflammation of the uveal tract (iris, ciliary body and 
choroid) is a common anterior segment 
manifestation of HIV. It is seen in up to 88% of 
HIV patients in Zimbabwe. Viral infections, 
tuberculosis and syphilis are the common etiological 
agents of infectious uveitis in HIV patients. In some 
cases, it is the initial presentation in undiagnosed 
patients. Idiopathic uveitis may occur in the 
background of immune reconstitution syndrome. 
This occurs when a patient whose cell mediated 
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immunity is being reconstituted as a result of 
treatment with HAART begins to develop uveitis as 
a part of autoimmune disease. Patients with uveitis 
will present with pain, photophobia, reduced vision 
and redness of the involved eye. Etiologic diagnosis 
can be made by examination of aqueous by use of 
polymerase chain reaction (PCR). 
Secondary Cataract  
We have seen and operated on young HIV positive 
patients in their early twenties who present with lens 
opacities that morphologically resemble juvenile 
cataract. These patients have no other associated 
conditions such as anterior iritis that would have 
accounted for their cataract. HIV induced lens 
changes may be responsible for this type of cataract. 
HIV virus has been isolated in lens tissue of patients 
with cataract. Visual prognosis following cataract 
surgery is good in this group of patients. Early 
surgery is important to prevent development of 
complications and to assure visual recovery, which 
will in turn help these patients to care for themselves 
and participate in the treatment of their illness. 
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A new email forum 
en-net is a new free online forum for people 
working in emergency nutrition and food security. 
The forum aims to provide fast access to support 
and guidance on challenging issues, prompt technical 
advice, and space for informal discussions and links 
to key resources. Users can receive email 
notifications of new postings, or simply visit the site 
to view and participate in 'question and answer' 
discussions.  
en-net is managed by the Emergency Nutrition 
Network www.ennonline.net and supported by 




March 8 2009 was International Women’s Day 
with theme of ‘Women and men united to end 
violence against women and girls." We hope to have 
some articles on this topic this soon.  
 
 
Did you know? 
A woman in South Sudan has a one in six chance of 
dying during the course of her lifetime from 
complications during pregnancy or delivery, 
according to the UN Children's Fund (UNICEF). 
Sudan's overall maternal mortality ratio is 1,107 
deaths per 100,000 live births, but rates are far higher 
in the South, rising to 2,243 deaths per 100,000 live 
births, according to UNICEF. 
